German chemical company Lanxess AG has reported an 11% increase in sales in the second quarter of 2005, to reach  €1.86 billion compared with €1.67 billion in 2004..

Restructuring measures already initiated and the consistent pursuit of our price-before-volume strategy have had a positive effect on earnings,” explained Lanxess management board chairman Axel C. Heitmann. However, we continue to suffer from structural disadvantages. The realignment of the Lanxess Group will therefore remain our top priority so that we can catch up with the competition in terms of earnings.”

Share this story: